CLIN TRANSL MED 润色咨询

Clinical and Translational Medicine

出版年份:2012 年文章数:514 投稿命中率: 开通期刊会员,数据随心看

出版周期:季刊 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2024-01-15 ms4000001214643575 来自湖北省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:基因组测序;肿瘤
    经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2023-08-21 1481ab03m35(暂无昵称) 来自上海

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:生物医学;合成生物学;癌症治疗
    经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;
    第一投稿,格式审查一周;
    第二,编辑部审查1周到两周;
    第三,外审2到4周;
    第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;
    第五,小修,修会后先格式审查,再编辑部审查;
    第六,接受,校稿,缴费
    第七,In production 等出版

    14

    展开14条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2024-02-23 科研小白白白白alz 来自湖北省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:神经系统疾病
    经验分享:审稿人偏多,一般5-6个(可能同时找10几个)
    01-Nov-2023 submit;
    25-Nov-2023 major revision(五个审稿人,给两个月时间);
    30-Jan-2024 revision submit;
    19-Feb-2024 minor revision(二审加送一个审稿人);
    21-Feb-2024 revision submit;
    22-Feb-2024 accept

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2024-01-18 victorjohn 来自江苏省

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2024-03-11 ms2000000319329547 来自北京

    一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2021-04-03 148c69cbm40暂无昵称

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online

    12

    展开12条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2023-10-17 a201061519 来自河南省

    偏重的研究方向:肿瘤
    经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2020-09-11 ms2000001076871723

    这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2024-01-09 ms3000000820351175 来自北京

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:脑血管病
    经验分享:Undergoing initial checking 10天
    under review 2天
    pending recommendation 了
    是不是凉了

    10

    展开10条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2181730, encodeId=03992181e30ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:基因组测序;肿瘤<br>经验分享:一审回来给了两个月,补实验时间有点紧,实在补不完,想申请延期一个月,多次通过投稿系统和通讯作者邮箱给编辑部发邮件申请延期没有收到任何回复,现在系统已经没有提交返修的选项了,还有什么办法吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81768664603, createdName=ms4000001214643575, createdTime=Mon Jan 15 10:55:13 CST 2024, time=2024-01-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153845, encodeId=63eb215384554, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生物医学;合成生物学;癌症治疗<br>经验分享:整体投稿流程较为顺利,但是各个时间节点周期较长;<br>第一投稿,格式审查一周;<br>第二,编辑部审查1周到两周;<br>第三,外审2到4周;<br>第四,大修,修回后先格式审查,再编辑部审查,再回到审稿人处审稿,基本1到2个月周期;<br>第五,小修,修会后先格式审查,再编辑部审查;<br>第六,接受,校稿,缴费<br>第七,In production 等出版, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Mon Aug 21 12:51:24 CST 2023, time=2023-08-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2188951, encodeId=82882188951ff, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经系统疾病<br>经验分享:审稿人偏多,一般5-6个(可能同时找10几个)<br>01-Nov-2023 submit;<br>25-Nov-2023 major revision(五个审稿人,给两个月时间);<br>30-Jan-2024 revision submit;<br>19-Feb-2024 minor revision(二审加送一个审稿人);<br>21-Feb-2024 revision submit;<br>22-Feb-2024 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a62307215, createdName=科研小白白白白alz, createdTime=Fri Feb 23 18:09:13 CST 2024, time=2024-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2182525, encodeId=e8e4218252583, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一审返回了15个审稿人意见,家人们,太疯狂了。读完意见花了一个小时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b181623105, createdName=victorjohn, createdTime=Thu Jan 18 23:42:36 CST 2024, time=2024-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192559, encodeId=c0ea2192559a6, content=一审23天,二审32天,pending 25天,现在三审,已经pending 11天了,好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a265448304, createdName=ms2000000319329547, createdTime=Mon Mar 11 14:09:33 CST 2024, time=2024-03-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=953692, encodeId=8aea953692bb, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第一次投稿没有送外审 被编辑直接拒稿 但是副编辑给了修改为letter重新投的机会 于是修改为letter后重新投稿送外审 一审一个月左右 小修 修回后三天左右接收很快online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2bf35329265, createdName=148c69cbm40暂无昵称, createdTime=Sat Apr 03 23:54:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163286, encodeId=b4782163286ee, content=偏重的研究方向:肿瘤<br>经验分享:期刊现在文章水平越来越高了!非常有潜力股的期刊~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Oct 17 12:07:14 CST 2023, time=2023-10-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=884439, encodeId=90ab88443934, content=这杂志一开始要求补大量实验,补不完就请求延期,但是请求之后没人理,最后到期系统自动关闭。感觉被戏弄了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73865417328, createdName=ms2000001076871723, createdTime=Fri Sep 11 08:43:44 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180219, encodeId=3f4b2180219ea, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:脑血管病<br>经验分享:Undergoing initial checking 10天<br>under review 2天<br>pending recommendation 了<br>是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Tue Jan 09 11:34:11 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180892, encodeId=de60218089219, content=一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Fri Jan 12 07:04:11 CST 2024, time=2024-01-12, status=1, ipAttribution=北京)]
    2024-01-12 洛洛仔111 来自北京

    一篇letter二审两个月了,分别给主编副主编和他们帮助邮箱发邮件催稿杳无音信,哎,太慢了

    3

    展开3条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分